AkzoNobel

AkzoNobel acquires majority ownership of Japanese joint venture

17 Dec, 2008 08:31 CET

AkzoNobel has agreed to acquire a 75/25 majority interest in its Kayaku Akzo Co. Ltd (KAC) joint venture with Nippon Kayaku.
KAC has been a 50/50 joint venture between the two companies for nearly 40 years. A leading supplier of organic peroxides to Japan, the business has sales offices in Tokyo and Osaka, Japan, as well as a manufacturing and research and development facility in Asa.

“This opportunity...

AkzoNobel completes REACH pre-registration

5 Dec, 2008 13:00 CET

AkzoNobel has submitted its list of substances in compliance with the European Union’s REACH legislation.
The company completed the process ahead of the December 1 cut-off date and has pre-registered around 6,000 substances following the introduction of the directive in June 2007.

REACH (the EU’s regulation on the Registration, Evaluation, Authorization and Restriction of Chemicals) will transform the...

AkzoNobel opens Elotex production facility in China

11 Nov, 2008 10:41 CET

AkzoNobel Functional Chemicals has officially opened a new production site in Shanghai, China, for its Elotex building material additives business.
The facility, which produces redispersible powder polymers, has an annual capacity of around 20,000 tons and brings the total number of Elotex manufacturing plants worldwide to five.

“The new manufacturing plant in Shanghai is primarily focused to better serve...

Akzo Nobel divests PVC additives business

15 Mar, 2007 08:02 CET

Arnhem, the Netherlands, March 15, 2007 — Akzo Nobel has divested its Akcros Chemicals PVC additives business to UK-based private investment firm GIL Investments. Financial details were not disclosed.
Under the terms of the deal, the company’s sites in Eccles, UK, and New Brunswick in the United States—along with all of the approximately 160 employees at these locations—will be transferred to the new...

Historic joint launch for Akzo Nobel’s flagship reports

14 Mar, 2007 09:00 CET

Arnhem, the Netherlands, March 14, 2007 — Akzo Nobel has today published its Annual and Corporate Social Responsibility Reports for 2006—the first time that the company has launched both publications on the same day.
Highlighting Akzo Nobel’s commitment to maintaining transparent and effective stakeholder communication, the joint launch not only emphasizes the importance of CSR to the whole organization, but is...

Akzo Nobel Announces Intended Sale of Organon BioSciences to Schering-Plough for...

12 Mar, 2007 08:53 CET

Arnhem, the Netherlands, March 12, 2007 – Akzo Nobel is pleased to announce that on March 11, 2007, it received an offer for the purchase of its wholly owned subsidiary Organon BioSciences N.V. (OBS) from Schering-Plough for EUR 11 billion in cash. As a result, Akzo Nobel will no longer be proceeding with the partial IPO of OBS on Euronext Amsterdam.
The Board of Management and the Supervisory Board of Akzo...

Akzo Nobel approves separation and Board changes

1 Mar, 2007 09:27 CET

Arnhem, the Netherlands, March 1, 2007 — Following on from the recent announcement regarding the impending separation of the company, Akzo Nobel’s Board of Management and Supervisory Board formally decided, on February 28, to divest a minority stake in Organon BioSciences through a listing of approximately 20 to 30 percent of Organon BioSciences shares on Euronext Amsterdam.

Akzo Nobel confirms IPO timing of Organon BioSciences

26 Feb, 2007 10:00 CET

Arnhem, the Netherlands, Monday, February 26 - Akzo Nobel today confirms the start of the process to list Organon BioSciences N.V. (OBS) on Euronext Amsterdam. Investor pre-marketing is intended to take place during the first two weeks of March, with the management roadshow expected to commence shortly thereafter.
Akzo Nobel intends to proceed with the initial public offering of shares of OBS and plans to list...

Akzo Nobel reconfirms listing of Organon BioSciences

25 Jan, 2007 09:21 CET

Arnhem, the Netherlands, January 25, 2007 — Akzo Nobel has previously announced its intention to separate its Pharma business, preferably through a listing of approximately 20 to 30 percent of Organon BioSciences shares on Euronext in Amsterdam in early 2007.
Over the last few weeks, Akzo Nobel has received preliminary expressions of interest from a number of parties regarding an acquisition of Organon...

Akzo Nobel agrees to sell 50 percent stake in Flexsys

15 Dec, 2006 16:33 CET

Arnhem, the Netherlands, December 15, 2006 — Akzo Nobel has reached an agreement in principle to sell its 50 percent stake in rubber chemicals business Flexsys to joint venture partner Solutia Inc. Financial details were not disclosed.
The proposed deal also includes the sale of Akzo Nobel’s toll manufacturing operation for Flexsys at the company’s Kashima site in Japan.

“The recent realignment of our...

Releases - AkzoNobel

Found press releases